Pharmaceutical companies by one-year price change
How far the share price has moved over the last 52 weeks.
Erasca leads the 61 pharmaceutical companies ranked by one-year price change, at +403%, ahead of Spyre Therapeutics (+286%) and Oruka Therapeutics (+241%). Figures as of 18 Nov 2026, 18:41 UTC, from Yahoo Finance quotes.
Key facts
- Companies ranked
- 61
- First
- Erasca+403%
- Median
- +26.9%
- Combined market value
- AED 18.71T
- Countries
- 10
Market values as of .
All countries▾
All sectors▾
Pharmaceuticals▾
| # | Company | 1 year ↓ | Market cap | Price | Today | 1 year | Price, 30 days | Country |
|---|---|---|---|---|---|---|---|---|
| 1 | ErascaERAS · Health Care | +403% | AED 17.4B | AED 49.66 | 2.66% down | 403% up | ||
| 2 | Spyre TherapeuticsSYRE · Health Care | +286% | AED 33.8B | AED 355.94 | 3.30% up | 286% up | ||
| 3 | Oruka TherapeuticsORKA · Health Care | +241% | AED 24B | AED 353.37 | 0.11% down | 241% up | ||
| 4 | VeradermicsMANE · Health Care | +233% | AED 19.3B | AED 457.94 | 0.76% down | 233% up | ||
| 5 | Definium TherapeuticsDFTX · Health Care | +169% | AED 14.5B | AED 106.28 | 1.51% down | 169% up | ||
| 6 | Kiniksa Pharmaceuticals InternationalKNSA · Health Care | +126% | AED 27.5B | AED 350.14 | 0.23% up | 126% up | ||
| 7 | Dianthus TherapeuticsDNTH · Health Care | +113% | AED 18.1B | AED 321.08 | 0.51% up | 113% up | ||
| 8 | TG TherapeuticsTGTX · Health Care | +107% | AED 36.7B | AED 242.72 | 5.38% up | 107% up | ||
| 9 | ViatrisVTRS · Health Care | +95.5% | AED 87B | AED 75.90 | 1.05% up | 96% up | ||
| 10 | Roivant SciencesROIV · Health Care | +90.3% | AED 102.6B | AED 141.63 | 0.39% down | 90% up | ||
| 11 | Edgewise TherapeuticsEWTX · Health Care | +88.2% | AED 16.8B | AED 153.49 | 0.59% down | 88% up | ||
| 12 | Amneal PharmaceuticalsAMRX · Health Care | +83.3% | AED 28.3B | AED 81.15 | 4.62% up | 83% up | ||
| 13 | Royalty PharmaRPRX · Health Care | +77.7% | AED 146.6B | AED 254.95 | 1.07% up | 78% up | ||
| 14 | Teva Pharmaceutical IndustriesTEVA · Health Care | +74.4% | AED 180.7B | AED 154.87 | 1.07% down | 74% up | ||
| 15 | GenmabGMAB · Health Care | +70.0% | AED 116.7B | AED 189.21 | 0.86% down | 70% up | ||
| 16 | Praxis Precision MedicinesPRAX · Health Care | +61.1% | AED 31.7B | AED 1,134.38 | 1.24% up | 61% up | ||
| 17 | AlkermesALKS · Health Care | +58.4% | AED 29B | AED 172.55 | 3.37% up | 58% up | ||
| 18 | Takeda PharmaceuticalTAK · Health Care | +53.6% | AED 251.1B | AED 78.58 | 1.13% down | 54% up | ||
| 19 | Merck & CoMRK · Health Care | +50.8% | AED 1.25T | AED 508.59 | 3.42% down | 51% up | ||
| 20 | Protagonist TherapeuticsPTGX · Health Care | +46.4% | AED 30.2B | AED 463.01 | 1.11% up | 46% up | ||
| 21 | Travere TherapeuticsTVTX · Health Care | +44.2% | AED 18.1B | AED 188.05 | 0.20% up | 44% up | ||
| 22 | Ligand PharmaceuticalsLGND · Health Care | +42.6% | AED 22.1B | AED 1,104.90 | 2.39% up | 43% up | ||
| 23 | Johnson & JohnsonJNJ · Health Care | +37.6% | AED 2.44T | AED 1,011.63 | 1.17% down | 38% up | ||
| 24 | Jazz PharmaceuticalsJAZZ · Health Care | +36.7% | AED 58.3B | AED 907.52 | 2.65% up | 37% up | ||
| 25 | Regeneron PharmaceuticalsREGN · Health Care | +36.3% | AED 360.2B | AED 3,482.35 | 1.01% down | 36% up | ||
| 26 | Eli LillyLLY · Health Care | +34.9% | AED 4.57T | AED 5,127.00 | 1.39% down | 35% up | ||
| 27 | Bristol-Myers SquibbBMY · Health Care | +34.0% | AED 452B | AED 221.11 | 1.87% down | 34% up | ||
| 28 | Belite BioBLTE · Health Care | +31.0% | AED 23.5B | AED 578.96 | 0.06% down | 31% up | ||
| 29 | Mirum PharmaceuticalsMIRM · Health Care | +30.5% | AED 22.2B | AED 339.47 | 0.52% up | 31% up | ||
| 30 | Ascendis PharmaASND · Health Care | +27.8% | AED 65.5B | AED 998.55 | 0.25% up | 28% up | ||
| 31 | Vertex PharmaceuticalsVRTX · Health Care | +26.9% | AED 501.9B | AED 1,979.73 | 0.90% up | 27% up | ||
| 32 | AbbVieABBV · Health Care | +25.7% | AED 1.87T | AED 1,056.51 | 1.77% down | 26% up | ||
| 33 | NovartisNVS · Health Care | +25.0% | AED 1.08T | AED 573.12 | 1.94% down | 25% up | ||
| 34 | United TherapeuticsUTHR · Health Care | +22.6% | AED 91.2B | AED 2,141.04 | 0.20% down | 23% up | ||
| 35 | Elanco Animal HealthELAN · Health Care | +20.5% | AED 49.5B | AED 99.06 | 4.33% up | 20% up | ||
| 36 | BridgeBio PharmaBBIO · Health Care | +17.2% | AED 55.9B | AED 287.11 | 1.78% up | 17% up | ||
| 37 | BeOne MedicinesONC · Health Care | +16.8% | AED 170B | AED 1,488.52 | 1.93% down | 17% up | ||
| 38 | PfizerPFE · Health Care | +14.4% | AED 590.3B | AED 103.56 | 0.97% down | 14% up | ||
| 39 | Rhythm PharmaceuticalsRYTM · Health Care | +13.0% | AED 30.6B | AED 441.12 | 2.99% up | 13% up | ||
| 40 | BioMarin PharmaceuticalBMRN · Health Care | +11.3% | AED 43.1B | AED 222.50 | 3.53% up | 11% up | ||
| 41 | Arrowhead PharmaceuticalsARWR · Health Care | +10.3% | AED 22.6B | AED 159.70 | 1.14% up | 10% up | ||
| 42 | GSKGSK · Health Care | +6.26% | AED 359.4B | AED 179.31 | 0.85% down | 6% up | ||
| 43 | Dr. Reddy's LaboratoriesRDY · Health Care | +5.27% | AED 46.1B | AED 55.27 | 1.75% up | 5% up | ||
| 44 | AstraZenecaAZN · Health Care | +2.41% | AED 1.02T | AED 660.06 | 1.40% down | 2% up | ||
| 45 | GrifolsGRFS · Health Care | +1.41% | AED 21.2B | AED 31.09 | 1.91% down | 1% up | ||
| 46 | SanofiSNY · Health Care | -4.08% | AED 417.6B | AED 173.90 | 0.39% down | 4% down | ||
| 47 | Axsome TherapeuticsAXSM · Health Care | -7.37% | AED 26B | AED 494.52 | 0.96% down | 7% down | ||
| 48 | Corcept TherapeuticsCORT · Health Care | -7.92% | AED 27.5B | AED 250.82 | 2.54% down | 8% down | ||
| 49 | Novo NordiskNVO · Health Care | -16.9% | AED 641.6B | AED 145.58 | 2.62% down | 17% down | ||
| 50 | Abbott LaboratoriesABT · Health Care | -17.0% | AED 664.8B | AED 383.85 | 0.19% down | 17% down | ||
| 51 | PTC TherapeuticsPTCT · Health Care | -20.2% | AED 18.5B | AED 221.77 | 0.03% up | 20% down | ||
| 52 | CytokineticsCYTK · Health Care | -20.3% | AED 26.4B | AED 189.78 | 0.04% up | 20% down | ||
| 53 | Cogent BiosciencesCOGT · Health Care | -20.3% | AED 18B | AED 103.61 | 1.29% up | 20% down | ||
| 54 | Madrigal PharmaceuticalsMDGL · Health Care | -24.0% | AED 34.8B | AED 1,499.00 | 3.29% down | 24% down | ||
| 55 | ABIVAXABVX · Health Care | -27.3% | AED 27B | AED 308.52 | 2.31% up | 27% down | ||
| 56 | ZoetisZTS · Health Care | -28.7% | AED 127.1B | AED 312.73 | 1.99% up | 29% down | ||
| 57 | Summit TherapeuticsSMMT · Health Care | -35.6% | AED 30.9B | AED 38.66 | 1.36% down | 36% down | ||
| 58 | InsmedINSM · Health Care | -40.1% | AED 97.2B | AED 443.28 | 0.96% down | 40% down | ||
| 59 | Legend BiotechLEGN · Health Care | -42.5% | AED 11.6B | AED 59.65 | 0.81% up | 42% down | ||
| 60 | Ionis PharmaceuticalsIONS · Health Care | -63.6% | AED 17B | AED 102.31 | 3.32% up | 64% down | ||
| 61 | Alnylam PharmaceuticalsALNY · Health Care | -66.0% | AED 74.3B | AED 554.68 | 3.50% down | 66% down |
Sources: share prices and market values from Yahoo Finance; sector, country and category from each company's SEC registration.
Market value is share price × shares outstanding, from Yahoo Finance; prices may be delayed 15 minutes or more and the ranking refreshes about every 20 minutes. The list covers companies with shares listed in the US, which includes foreign companies listed through ADRs but not ones listed only abroad. Sector, category and country come from each company's SEC registration. Sums are converted from US dollars at today's exchange rate (1 USD = 3.6729 AED).
Questions and answers
Which pharmaceutical companies rank first by one-year price change?
Erasca (+403%), Spyre Therapeutics (+286%) and Oruka Therapeutics (+241%) are the top three of the 61 pharmaceutical companies ranked by one-year price change as of 18 Nov 2026, 18:41 UTC.
How many pharmaceutical companies are in this ranking?
61 are ranked by one-year price change.
What are these pharmaceutical companies worth together?
The 61 pharmaceutical companies ranked by one-year price change have a combined market value of AED 18.71T as of 18 Nov 2026, 18:41 UTC.
What does ranking by one-year price change measure?
How far the share price has moved over the last 52 weeks.
Learn how this ranking works
All markets guides →- 52-week high and low: what the range tells you
A stock's 52-week high and low are the highest and lowest prices it reached over the past year. Where today's price sits in that range, from 0% at the low to 100% at the high, shows how the past year has gone. Sources differ on whether they use closing or intraday prices, so the same stock's range can differ slightly.
- Drawdown and recovery: why a 50% fall needs a 100% gain
A drawdown is how far a price has fallen from its previous peak, as a percentage of that peak. Recovery needs a larger gain than the fall, because the gain starts from a smaller base: a 20% drop needs a 25% rise to get back, a 50% drop needs 100%, and a 75% drop needs 300%.
- How an ETF's size is measured: AUM, NAV and creation units
An ETF's size is usually measured by its assets under management (AUM), the fund's net assets: everything it holds minus what it owes. That equals net asset value per share times shares outstanding. AUM grows when the holdings rise in value and when large institutions create new shares, and shrinks when they redeem them.
Cite this page
Funkfolio, “Pharmaceutical companies by one-year price change”, data as of 18 November 2026. https://funkfolio.com/companies/category/pharmaceuticals?by=year-change
Underlying data: Yahoo Finance; SEC EDGAR.